This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

HJ Jung
Vice President at ST Pharm
Speaker

Profile

HJ holds a degree in Chemistry from Yonsei University and completed graduate studies at the same institution. As a senior executive at ST Pharm, Asia’s leading CDMO in the field of oligonucleotides and small molecules, he has been at the forefront of the company’s global expansion and technological innovation for nearly two decades. With deep scientific expertise and sharp business insight, HJ has led the development and commercialization of cutting-edge therapeutics, reinforcing ST Pharm’s position as a regional powerhouse and a trusted global partner. His leadership continues to shape the future of the pharmaceutical industry in Asia and beyond.

Agenda Sessions

  • ST Pharm's Journey as a Solution Provider for RNA-based Therapeutics: From Metric Ton Provider of ASOs and siRNAs to guide RNA, mRNA, circRNA and their Formulations

    11:50